Extreme preterm neonate with fetal warfarin syndrome

Risa Birbal; Olushola Olaniyi; Paul Clarke

doi:10.1136/archdischild-2021-323295

Extreme preterm neonate with fetal warfarin syndrome

Risa Birbal, Olushola Olaniyi, Paul Clarke

Norwich Medical School

Research output: Contribution to journal › Article › peer-review

9 Downloads (Pure)

Abstract

A 25+3 week gestation male infant weighing 493 g was delivered via caesarean section for intrauterine growth restriction and abnormal Dopplers. The mother was on long-term thromboprophylactic warfarin 5 mg/day due to her prosthetic mechanical heart valve following childhood rheumatic fever. Once pregnancy was diagnosed, at 4+0 weeks’ gestation, warfarin was discontinued and low-molecular-weight heparin was started. Warfarin was recommenced at 12+1 weeks’ gestation after a small maternal stroke.

Original language	English
Pages (from-to)	293-294
Number of pages	2
Journal	Archives of Disease in Childhood - Fetal and Neonatal Edition
Volume	108
Issue number	3
Early online date	23 Dec 2021
DOIs	https://doi.org/10.1136/archdischild-2021-323295
Publication status	Published - 1 May 2023

Keywords

neonatology
syndrome

Access to Document

10.1136/archdischild-2021-323295

Accepted_MnauscriptAccepted author manuscript, 304 KB

https://fn.bmj.com/content/fetalneonatal/108/3/293.full.pdf

Cite this

@article{449825d4229e410f957af9af8a911db1,

title = "Extreme preterm neonate with fetal warfarin syndrome",

abstract = "A 25+3 week gestation male infant weighing 493 g was delivered via caesarean section for intrauterine growth restriction and abnormal Dopplers. The mother was on long-term thromboprophylactic warfarin 5 mg/day due to her prosthetic mechanical heart valve following childhood rheumatic fever. Once pregnancy was diagnosed, at 4+0 weeks{\textquoteright} gestation, warfarin was discontinued and low-molecular-weight heparin was started. Warfarin was recommenced at 12+1 weeks{\textquoteright} gestation after a small maternal stroke.",

keywords = "neonatology, syndrome",

author = "Risa Birbal and Olushola Olaniyi and Paul Clarke",

year = "2023",

month = may,

day = "1",

doi = "10.1136/archdischild-2021-323295",

language = "English",

volume = "108",

pages = "293--294",

journal = "Archives of Disease in Childhood-Fetal and Neonatal Edition",

issn = "1359-2998",

publisher = "BMJ Publishing Group",

number = "3",

}

TY - JOUR

T1 - Extreme preterm neonate with fetal warfarin syndrome

AU - Birbal, Risa

AU - Olaniyi, Olushola

AU - Clarke, Paul

PY - 2023/5/1

Y1 - 2023/5/1

N2 - A 25+3 week gestation male infant weighing 493 g was delivered via caesarean section for intrauterine growth restriction and abnormal Dopplers. The mother was on long-term thromboprophylactic warfarin 5 mg/day due to her prosthetic mechanical heart valve following childhood rheumatic fever. Once pregnancy was diagnosed, at 4+0 weeks’ gestation, warfarin was discontinued and low-molecular-weight heparin was started. Warfarin was recommenced at 12+1 weeks’ gestation after a small maternal stroke.

AB - A 25+3 week gestation male infant weighing 493 g was delivered via caesarean section for intrauterine growth restriction and abnormal Dopplers. The mother was on long-term thromboprophylactic warfarin 5 mg/day due to her prosthetic mechanical heart valve following childhood rheumatic fever. Once pregnancy was diagnosed, at 4+0 weeks’ gestation, warfarin was discontinued and low-molecular-weight heparin was started. Warfarin was recommenced at 12+1 weeks’ gestation after a small maternal stroke.

KW - neonatology

KW - syndrome

UR - http://www.scopus.com/inward/record.url?scp=85153120698&partnerID=8YFLogxK

U2 - 10.1136/archdischild-2021-323295

DO - 10.1136/archdischild-2021-323295

M3 - Article

VL - 108

SP - 293

EP - 294

JO - Archives of Disease in Childhood-Fetal and Neonatal Edition

JF - Archives of Disease in Childhood-Fetal and Neonatal Edition

SN - 1359-2998

IS - 3

ER -

Extreme preterm neonate with fetal warfarin syndrome

Abstract

Keywords

Access to Document

Other files and links

Cite this